These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34537047)

  • 1. Use of large scale EHR data to evaluate A1c utilization among sickle cell disease patients.
    Sivasankar S; Cheng AL; Lubin IM; Lankachandra K; Hoffman MA
    BMC Med Inform Decis Mak; 2021 Sep; 21(1):268. PubMed ID: 34537047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin A
    McLean A; Wright F; deJong N; Skinner S; Loughlin CE; Levenson A; Carden MA
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28499. PubMed ID: 32618413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking Methodology to Evaluate the Severity of a Quality Gap Using a National EHR Database.
    Sivasankar S; Cheng AL; Hoffman M
    AMIA Jt Summits Transl Sci Proc; 2021; 2021():565-574. PubMed ID: 34457172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis.
    Lindsey CC; Carter AW; Mangum S; Greene D; Richardson A; Brown S; McCandless B
    Diabetes Technol Ther; 2002; 4(5):637-42. PubMed ID: 12450445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care.
    Lindsey CC; Carter AW; Mangum S; Greene D; Richardson A; Brown SJ; Essary JL; McCandless B
    Diabetes Technol Ther; 2004 Jun; 6(3):370-7. PubMed ID: 15198841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adoption of an electronic health record did not improve A1c values in Type 2 diabetes.
    Burke HB; Becher DA; Hoang A; Gimbel RW
    J Innov Health Inform; 2016 Apr; 23(1):144. PubMed ID: 27348484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
    Kang HA; Barner JC
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum fructosamine and glycemic status in the presence of the sickle cell mutation.
    Doumatey AP; Feron H; Ekoru K; Zhou J; Adeyemo A; Rotimi CN
    Diabetes Res Clin Pract; 2021 Jul; 177():108918. PubMed ID: 34126128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
    Singh A; Sontag MK; Zhou M; Dasgupta M; Crume T; McLemore M; Galadanci N; Randall E; Steiner N; Brandow AM; Koch K; Field JJ; Hassell K; Snyder AB; Kanter J
    JMIR Public Health Surveill; 2023 Jun; 9():e42816. PubMed ID: 37379070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden Death in Diabetic Ketoacidosis Complicated by Sickle Cell Trait.
    Dau GE; Shah JJ; Walsh JC; Berran PJ
    Am J Forensic Med Pathol; 2022 Sep; 43(3):277-281. PubMed ID: 35135968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.
    Vekeman F; Sasane M; Cheng WY; Ramanakumar AV; Fortier J; Qiu Y; Duh MS; Paley C; Adams-Graves P
    J Med Econ; 2016; 19(3):292-303. PubMed ID: 26618853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misleading hemoglobin A1c levels in a patient with paroxysmal nocturnal hemoglobinuria.
    Xia D; McShine R; Berg AH
    Am J Clin Pathol; 2014 Aug; 142(2):261-5. PubMed ID: 25015870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the status of diabetes mellitus during a 2-year period using traditional methods and determination of glycosylated hemoglobin A1c and fructosamine in the blood].
    Páv J; Hilgertová J; Skrha J
    Cas Lek Cesk; 1991 Nov; 130(18-19):534-8. PubMed ID: 1764715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends of hemoglobin A1c testing.
    Pivovarov R; Albers DJ; Hripcsak G; Sepulveda JL; Elhadad N
    J Am Med Inform Assoc; 2014; 21(6):1038-44. PubMed ID: 24928176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed Influence of Electronic Health Record Implementation on Diabetes Order Patterns for Michigan Medicaid Adults.
    Corser W; Yuan S
    J Diabetes Sci Technol; 2015 Aug; 10(2):429-34. PubMed ID: 26292961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetes.
    Lee JE; Lee JW; Fujii T; Fujii N; Choi JW
    Biomed Res Int; 2014; 2014():370790. PubMed ID: 25013775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
    Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.